G(q) plays a major role in the EGFR pathway leading to AngII-induced vascular hypertrophy, highlighting it as a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
G(q) inhibition merits further preclinical study in vascular hypertrophy; leaves open any clinical translation.
Ohtsu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: